Highly precise radiopharmaceuticals can be used to effectively diagnose or treat tumors expressing specific receptors on their surface. Watch the video to learn more about their mode of action (MoA).

Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.